PSUSA/00010525/202404

PSUSA/00002001/202404

Human medicines European public assessment report (EPAR): Gavreto, pralsetinib, Date of authorisation: 18/11/2021, Revision: 8, Status: Withdrawn

Opening procedures at EMA to non-EU authorities (OPEN) framework

Human medicines European public assessment report (EPAR): Kinzalkomb, telmisartan,hydrochlorothiazide, Date of authorisation: 19/04/2002, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): PritorPlus, telmisartan,hydrochlorothiazide, Date of authorisation: 22/04/2002, Revision: 39, Status: Authorised

Two new vaccines against bluetongue recommended for approval

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 January 2025

Human medicines European public assessment report (EPAR): Pravafenix, fenofibrate,pravastatin, Date of authorisation: 14/04/2011, Revision: 11, Status: Authorised

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025